ID 800 - Izomaltooligosacharydy

PL: Izomaltooligosacharydy
EN: Isomalto-oligosaccharides
Pdf: isomalto-oligosaccharides

Oświadczenie (2)

1. Charakterystyka żywności / składnika

The food constituent that is the subject of the health claims is isomalto-oligosaccharides. Isomalto- oligosaccharides (IMO) are produced by enzymatic hydrolysis of starch and consist mainly of oligomers of isomaltose, panose, isomaltotriose and isomaltotetraose connected by non-digestible α 1→6 glucosidic linkages. IMO do not occur naturally in foods. IMO can be quantified in foods by established methods.
The Panel considers that the food constituent, isomalto-oligosaccharides, which is the subject of the health claims, is sufficiently characterised.

2.2. Zwiększenie częstości codziennych wypróżnień (ID 800)

The claimed effects are “normal bowel function/gastrointestinal function/colonic function”. The Panel assumes that the target population is individuals with constipation.
In the context of the clarifications provided by Member States, the Panel assumes that the claimed effect is related to an increase in the frequency of daily bowel movements.
The Panel considers that an increase in the frequency of daily bowel movements within the normal range might be a beneficial physiological effect.

3.2. Zwiększenie częstości codziennych wypróżnień (ID 800)

The information provided consisted of two references which reported on human intervention studies.
In a non-controlled, single arm, intervention seven elderly males followed a control low-fibre diet for 30 days and were then administered 10 g/d of IMO for the next 30 days (Chen et al., 2001). The second study was a single-arm, non-controlled, intervention conducted in 20 haemodialysis patients who consumed 30 g/d IMO for 4 weeks after a 2-week run in period (Wang et al., 2001). The Panel notes the small number of subjects studied and the lack of a control group. The Panel considers that no conclusions can be drawn from these uncontrolled studies for the scientific substantiation of the claimed effect.
The Panel concludes that a cause and effect relationship has not been established between the consumption of isomalto-oligosaccharides and an increase in the frequency of daily bowel movements.

Warunki i możliwe ograniczenia stosowania oświadczenia

The recommended dosage for Vitasugar (Bioneutra Inc. Isomalto-oligosaccharide product) is 30g per day. No adverse effects reported. Women who are pregnant or planning a pregnancy should consult a healthcare professional before taking any food supplement